How can dermatologists address challenges and disparities in access to vitiligo care?

Featuring Karan Lal, DO, MS, FAAD |

Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ

| Published April 01, 2024

More from this series

Who is the ideal patient for ruxolitinib for vitiligo?

Vitiligo

Who is the ideal patient for ruxolitinib for vitiligo?

Featuring Karan Lal, DO, MS, FAAD

What is the role of the JAK-STAT pathway in vitiligo?

Vitiligo

What is the role of the JAK-STAT pathway in vitiligo?

Featuring Karan Lal, DO, MS, FAAD

What are the limitations of use for ruxolitinib for vitiligo?

Vitiligo

What are the limitations of use for ruxolitinib for vitiligo?

Featuring Karan Lal, DO, MS, FAAD

What is the safety profile of ruxolitinib for vitiligo?

Vitiligo

What is the safety profile of ruxolitinib for vitiligo?

Featuring Karan Lal, DO, MS, FAAD